Robert Lufkin: Anti-Amyloid Drugs Fail Alzheimer’s Patients
Robert Lufkin, Advisor of Metabolic Health and Longevity Expert, shared post on LinkedIn:
“A Cochrane review of 17 trials and 20,342 patients concluded anti-amyloid drugs offer no clinically meaningful benefit for Alzheimer’s.
As a medical school professor, I have watched the amyloid hypothesis dominate Alzheimer’s research for 30 years.
Findings:
- 17 trials, 20,342 patients
- Effects on cognitive decline absent or trivial
- The drugs remove amyloid but raise brain bleeding and swelling risk
- Authors call for research on other mechanisms
Lead author Dr. Francesco Nonino:
‘These drugs make no meaningful difference to patients.’
This is the textbook story I called out in ‘Lies I Taught in Medical School.’
The amyloid hypothesis was elegant.
As a target, it was wrong.
Growing evidence points to Alzheimer’s as a metabolic disease – driven by insulin resistance, glucose hypometabolism, and mitochondrial dysfunction.
Metabolic dysfunction is the root cause of chronic disease.
Full breakdown coming on the Health Longevity Secrets podcast.
View Cochrane review.”
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 30, 2026, 18:36Amina Ammar: Evaluating Rivaroxaban Dosing Alignment Across Cockcroft–Gault and eGFR Equations
-
Jul 30, 2026, 18:11Tobias Tritschler: Evaluating Timing, Translation and Preparedness in COVID-19 Anticoagulation Management
-
Jul 30, 2026, 16:05Peter Zdziarski: Today is Chronic Disease Awareness Day
-
Jul 30, 2026, 15:50Ahmad Gharehbaghian: New Blood Transfusion Centers Open in Iran
-
Jul 30, 2026, 15:32Can We Better Protect Hospitalized Patients With Obesity From Venous Thromboembolism? – RPTH Journal
-
Jul 30, 2026, 15:162025 Platelet Transfusion Thresholds: When to Transfuse and When Not to Transfuse – Chokri Ben Lamine
-
Jul 30, 2026, 14:34Flora Peyvandi: Genetics of Early-Onset Coronary Artery Disease in Iranians
-
Jul 30, 2026, 14:22Stéphanie Forté: New Evidence Strengthens the Case for Hydroxyurea in HbSC Disease
-
Jul 30, 2026, 14:09Hilal Ahmad: New Guidelines for Pediatric Ischemic Stroke Management